A Survey study to evaluate treatment adherence to Subcutaneous Interferon beta-1a versus Dimethyl fumarate in patients with multiple sclerosis
Latest Information Update: 11 May 2018
At a glance
- Drugs Dimethyl fumarate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 11 May 2018 New trial record
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology